BioCentury
ARTICLE | Clinical News

Unoprostone isopropyl: Phase III data

March 16, 2015 7:00 AM UTC

Top-line data from a double-blind, Japanese Phase III trial in about 180 patients showed that 0.15% unoprostone isopropyl eye drops missed the primary endpoint of improving mean retinal sensitivity at...